Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282978
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2023-11-23
Brief Title:
Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation